Intellia Therapeutics Inc (NASDAQ:NTLA)

117.25
Delayed Data
As of Dec 07
 +16.49 / +16.37%
Today’s Change
43.86
Today|||52-Week Range
202.73
+115.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues6.0M16.5M26.1M30.4M
 
 
 
 
 
Depreciation And Amortization328.0K1.1M3.0M4.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.1M47.5M92.7M116.8M
 
 
 
 
 
Research And Development11.2M31.8M67.6M89.1M
 
 
 
 
 
Total Operating Expenses19.5M48.6M95.7M121.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.4M-32.2M-69.6M-90.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.4M-31.6M-67.5M-85.3M
 
 
 
 
 
Income Taxes-1.0M0.000.000.00
 
 
Net Income-12.4M-31.6M-67.5M-85.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.0M22.2M36.0M43.1M
 
 
 
 
 
Shares To Calculate EPS Diluted36.0M22.2M36.0M43.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$51.02-$1.42-$1.88-$1.98
 
 
 
 
 
EPS Diluted-$0.34-$1.42-$1.88-$1.98